Anti-Snoring Devices And Snoring Surgery Market is anticipated to grow at a 8.35% CAGR, growing from USD 1.873 billion in 2025 to USD 3.031 billion in 2031.
There are various approaches to addressing snoring, ranging from lifestyle changes and anti-snoring devices to medical interventions like surgery. The increasing prevalence of sleep disorders coupled with the increasing awareness regarding sleep disorder prevention and symptoms are major growth drivers of anti-snoring devices and the snoring surgery market. Moreover, changing lifestyles, the growing elderly population along with technological developments leading to enhanced devices and minimally invasive surgeries are further expected to propel the market expansion.
Increasing Sleep Disorders
The prevalence of sleep disorders, including sleep apnea, has been on the rise. Snoring is often a symptom of such disorders. The medical community's focus on diagnosing and treating these conditions has fueled the demand for both diagnostic tools and treatment options thereby boosting the anti-snoring devices and surgery market. For instance, 45% of Americans say that lack of sleep has affected their everyday lives at least once in the past seven days according to the Start Sleeping Organization. Moreover, sleep apnea may impact over one billion individuals worldwide according to the Sleep Education Organization.
Growing Awareness of Sleep Disorders
As public awareness of sleep-related disorders like snoring and sleep apnea increases, more individuals are seeking solutions to improve their sleep quality and overall health. This awareness is contemplated to bolster the anti-snoring devices and snoring surgery market. For instance, in October 2020, Philips introduced an innovative online Sleep Medicine Course that spans six months and is the first of its kind, offering comprehensive certification in the field of sleep medicine. The Academy of Pulmonary Critical Care and Sleep Medicine (APCCSM) and the Indian Sleep Disorders Association (ISDA) collaborated to co-organize the course. Moreover, National Sleep Awareness Week is organized every year in March by National Sleep Foundation (USA) to reemphasize the important connection between sleep and health.
Changing Lifestyle
Modern lifestyle factors such as obesity, sedentary habits, and poor dietary choices can contribute to snoring. As these issues become more prevalent, the anti-snoring devices and snoring surgery market is likely to grow in the coming years. For instance, according to the WHO, around 2.8 million people die from obesity or overweight each year. According to the World Obesity Atlas 2022 published by World Obesity Federation, it is estimated that 1 in 5 women and 1 in 7 women will live with obesity by 2030. As per NCBI, adults in the United States typically spend an average of 7.7 hours per day sitting, while the Korean population spends approximately 8.3 hours sitting daily.
Technological Advancements
Technological advancements have significantly impacted the anti-snoring devices and snoring surgery market leading to more effective, convenient, and personalized solutions for individuals experiencing snoring and sleep-related issues. For example, many anti-snoring devices now come with companion mobile apps that allow users to track their progress, receive personalized recommendations, and adjust device settings. These apps can also facilitate communication between users and their healthcare providers for remote monitoring and guidance. RFA technology has improved with the development of more precise and controlled devices. This allows for targeted treatment of specific tissues to reduce snoring and related sleep issues.
The anti-snoring devices and snoring surgery market has experienced growth and development however some restraints or challenges can impact its expansion. For example, not all anti-snoring devices and surgical procedures are equally effective for everyone. Individual variations in the underlying causes of snoring can lead to varying levels of success with different interventions. Additionally, individuals may be hesitant to undergo surgery due to concerns about potential complications, pain, and recovery time. This reluctance can limit the adoption of surgical interventions. Further, Sleep apnea is frequently misdiagnosed. For instance, it is estimated by the Sleep Education Organization that over 23.5 million persons in the United States suffer undiagnosed sleep apnea.
North America is Expected to Grow Considerably
North America is expected to hold a significant share of the anti-snoring devices and snoring surgery market during the forecast period. The factors attributed to such a share are a higher prevalence of sleep disorders, technological developments, increased awareness, and a higher burden of obesity and other underlying factors of snoring. For instance, the prevalence of obesity in the US increased from 4.7 in 2017 to 9.4 in 2021 as per the Centre for Disease Control and Prevention. Moreover, in the United States, inadequate sleep is projected to cost more than $411 billion each year according to the Sleep Foundation.
Somnowell INC. is known for its development and production of oral devices used in the treatment of snoring, sleep apnea, and related sleep disorders. The Somnowell device falls under the category of mandibular advancement devices (MADs), which are commonly used to treat mild to moderate obstructive sleep apnea (OSA) and snoring.
Inspire Sleep is a medical technology company that specializes in the treatment of obstructive sleep apnea (OSA). It developed an inventive medical device known as the "Inspire therapy" system, intended to offer an alternate treatment choice for people dealing with moderate to severe obstructive sleep apnea (OSA) and who cannot endure or gain from continuous positive airway pressure (CPAP) therapy.
Zelegent is a US-based medical technology company specializing in treatment solutions for snoring and sleep-related breathing disorders. One of their notable products is the Elevo device which is designed to address snoring and mild obstructive sleep apnea (OSA) by targeting the soft palate. The Elevo device is intended to be a minimally invasive solution and it involves a procedure performed under local anesthesia.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 β 2031 |
| Companies |
|
Report Metric | Details |
Breath Analyzer Market Size in 2025 | USD 2.081 billion |
Breath Analyzer Market Size in 2030 | USD 2.943 billion |
Growth Rate | CAGR of 8.61% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 β 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in the Breath Analyzer Market |
|
Customization Scope | Free report customization with purchase |
Anti-Snoring Devices and Snoring Surgery Market Segmentation
By Device Type
Oral Appliances
Nasal Devices
Chin Devices
Tongue-Stabilizing Devices
Others
By Surgical Procedure
Radiofrequency Ablation
Pillar Procedure
Injection Snoreplasty
Palatal Stiffening
Others
By End-User
Hospitals
Clinics
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Others